Family Medicine · Monterey Park, CA
NPI
1801855028
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
5
Medicare group memberships
Hospitals
0
Hospital affiliations
210 N Garfield Ave, Suite 201
Monterey Park, CA, 91754
Phone (626) 280-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$661K
13,028 services
Medicare patients, 2024
678
Average age 78
Drug cost, 2024
$3.9M
17,052 prescriptions
Company payments, 2025
$6,599
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Singh A Boun was code 99490 (chronic, principal, and transitional care management), 5,741 times for 533 patients. In total Singh A Boun billed 13,028 services in 50 codes, and Medicare paid $661K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-08-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 5,741 | 533 | $52.31 | $300K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,799 | 446 | $13.01 | $23K |
| 99214 Office E&M - Established | Office | 1,163 | 330 | $99.80 | $116K |
| 99213 Office E&M - Established | Office | 1,148 | 389 | $73.34 | $84K |
| 99457 E&M - Miscellaneous | Office | 856 | 139 | $42.52 | $36K |
| 99454 E&M - Miscellaneous | Office | 266 | 54 | $43.96 | $12K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 205 | 205 | $20.73 | $4,249 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 201 | 201 | $26.52 | $5,330 |
| 99497 Care Management/Coordination | Office | 196 | 194 | $83.46 | $16K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 185 | 185 | $20.76 | $3,840 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 182 | 182 | $138.57 | $25K |
| 96372 Injection Administration | Office | 174 | 77 | $11.76 | $2,046 |
| 36415 Venipuncture Blood Collection | Office | 140 | 113 | $8.65 | $1,211 |
| 36410 Vascular | Office | 102 | 89 | $13.91 | $1,419 |
| 93922 Duplex Scan - Extremity Arteries | Office | 98 | 98 | $72.20 | $7,075 |
By year: 2022 $821K for 14,202 services; 2023 $738K for 12,620 services; 2024 $661K for 13,028 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 140 | 113 | $8.65 | $1,211 |
Medicare prescription drug claims, 2024
In 2024, the drug Singh A Boun prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 738 prescriptions and refills. In total Singh A Boun wrote 17,052 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 738 | 939 | 163 | $327K |
| Rosuvastatin Calcium Generic | 637 | 947 | 153 | $4,206 |
| Atorvastatin Calcium Generic | 618 | 1,136 | 179 | $4,690 |
| Amlodipine Besylate Generic | 471 | 768 | 143 | $1,269 |
| Losartan Potassium Generic | 421 | 734 | 134 | $2,724 |
| Celecoxib Generic | 414 | 537 | 98 | $8,548 |
| Gabapentin Generic | 352 | 509 | 124 | $2,435 |
| Kerendia Finerenone | 344 | 404 | 66 | $258K |
| Icosapent Ethyl Generic | 327 | 429 | 102 | $79K |
| Dexlansoprazole Dr Dexlansoprazole | 322 | 417 | 76 | $72K |
| Farxiga Dapagliflozin Propanediol | 315 | 408 | 74 | $225K |
| Metoprolol Succinate Generic | 314 | 472 | 74 | $1,900 |
| Pantoprazole Sodium Generic | 293 | 456 | 81 | $1,998 |
| Jardiance Empagliflozin | 260 | 305 | 52 | $175K |
| Olmesartan Medoxomil Generic | 259 | 399 | 69 | $2,269 |
Brand drugs: 5,480 claims; generic drugs: 11,439 claims; opioid claims: 139.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Singh A Boun $6,599 ($6,599 in general payments such as food, travel and fees) from 32 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,363.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 40 | $1,363 |
| Amgen Inc. AMGN | 23 | $534 |
| GlaxoSmithKline, LLC. GSK | 20 | $487 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 13 | $343 |
| Ardelyx, Inc. ARDX | 9 | $326 |
| Pfizer Inc. PFE | 12 | $303 |
| IBSA Pharma Inc. | 20 | $290 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 10 | $269 |
| Lilly USA, LLC LLY | 11 | $253 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $252 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.